Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1

Status

Completed 4Not yet recruiting 2Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 4Gastrointestinal 2

Conditions

Uterine Cervical Neoplasms 4Uterine Cervical Dysplasia 2

Interventions

Paclitaxel 264Carboplatin 246Cisplatin 153Bevacizumab 104Gemcitabine 78Topotecan 77liposomal doxorubicin 67pembrolizumab 60Docetaxel 56Cyclophosphamide 50Taxes 48Radiotherapy 44olaparib 43Surveys and Questionnaires 43Doxorubicin 43Filgrastim 42Brachytherapy 37Drug Therapy 31niraparib 28Blood Specimen Collection 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 26human papillomavirus vaccine, L1 type 16, 18 24Peripheral Blood Stem Cell Transplantation 23atezolizumab 22Oxaliplatin 22Pemetrexed 21Nivolumab 21Hyperthermic Intraperitoneal Chemotherapy 21Etoposide 21Immunoglobulin G 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Acetic Acid × Gynecologic × Clear all
NCT02335372 2021-10-12

Cervical Cancer Screening Study in Brazil

M.D. Anderson Cancer Center

Phase NA Completed
300 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02420665 2021-05-28

Use of High-Resolution Microendoscopy (HRME) in Patients With Cervical Dysplasia

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Completed
50 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02029794 2017-05-03

ASPIRE

University of British Columbia

Phase NA Completed
500 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT02237326 2014-09-11

SAVE

University of California, San Francisco

Phase NA Completed
654 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡